Drug development based on functional genomics of overloaded cardiomyocytes: a novel approach for preventing progression of heart failure.
Rupp
Heinz
H
Molecular Cardiology Laboratory, Department of Internal Medicine and Cardiology, Philipps University of Marburg, Germany.
D000818:Animals; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D018450:Disease Progression; D015195:Drug Design; D004852:Epoxy Compounds / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D032383:Myocytes, Cardiac / Q000473:pathology; D051381:Rats; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases
D004852:Epoxy Compounds; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D000252:Calcium-Transporting ATPases; C054207:etomoxir